ArticlePloS one2025

The hidden risks of polypharmacy: Exploring potentially inappropriate prescribing with STOPP/START criteria version 3-A cross-sectional study.

Mikołaj Szoszkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.